Table 2 Demographic and clinical data of patients with CAP
From: Effects of community-acquired pneumonia on biventricular cardiac functions in children
Non-complicated CAP (n = 22) | Complicated CAP (n = 28) | P value | |
|---|---|---|---|
Sex Male Female | 14 (63.6%) 8 (36.4%) | 18 (64.3%) 10 (35.7%) | 0.962 |
Clinical manifestations Fever Grunting Chest pain Accessory muscle use Cough GIT manifestations | 20 (90.9%) 10 (45.5%) 2 (9.1%) 16 (72.7%) 8 (36.4%) 4 (18.2%) | 26 (92.9%) 14 (50.0%) 8 (28.6%) 22 (78.6%) 18 (64.3%) 16 (57.1%) | 0.801 0.749 0.087 0.631 0.05 0.005* |
Ineffective antibiotics | 4 (18.2%) | 10 (35.7%) | 0.171 |
Lung lobe involved Right upper lobe Right upper &middle lobes Right middle &lower lobes Right lower lobe Whole right side Left lower lobe Whole left side Bilateral lobar | 2 (9.1%) 2 (9.1%) 0 (0.0%) 8 (36.4%) 4 (18.2%) 4 (18.2%) 0 (0.0%) 2 (9.1%) | 0 (0.0%) 0 (0.0%) 3 (10.7%) 12 (42.9%) 8 (28.6%) 1 (3.6%) 4 (14.3%) 0 (0.0%) | 0.021* |
Surgical intervention Chest tube Chest tube + Decortication Decortication | 10 (35.7%) 4 (14.3%) 4 (14.3%) | ||
Combined used antibiotics Cephalosporin-Ampicillin sulbactam Cephalosporin-Vancomycin Cephalosporin-Linezolid Carbapenem-Linezolid Levofloxacin-Linezolid Cephalosporin-Clindamycin | 16 (72.7%) 2 (9.1%) 4 (18.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) | 4 (14.3%) 8 (28.6%) 9 (32.1%) 3 (10.7%) 2 (7.1%) 2 (7.1%) | 0.002* |
Macrolides | 8 (36.4) | 8 (28.6%) | 0.558 |